Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Teva And Alvotech Strike US Biosimilars Pact

Deal Covers Five Biosimilar Candidates With $35bn Brand Value

05 Aug 2020

• By Dave Wallace

Hand - USA — The US deal covers five biosimilar candidates • Source: Shutterstock

Related Content

Alvotech And JAMP Partner On Canadian Biosimilars

15 Jan 2020

Teva Debuts US Rituximab At A 10% Discount

07 Nov 2019

Alvotech And Stada Make Biosimilars Pact

07 Nov 2019

Teva Sticks With 10% Discount For Trastuzumab

16 Mar 2020

Related Companies

Teva Pharmaceutical Industries Ltd.

Alvotech

Additional Topics

United States Deals Biosimilars Strategy BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.